LUMOS PHARMA INC's ticker is LUMO and the CUSIP is 55028X109. A total of 38 filers reported holding LUMOS PHARMA INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $403 | -64.5% | 122 | -64.5% | 0.00% | – |
| Q2 2023 | $1,135 | -0.4% | 344 | 0.0% | 0.00% | – |
| Q1 2023 | $1,139 | -8.3% | 344 | 0.0% | 0.00% | – |
| Q4 2022 | $1,242 | -58.6% | 344 | 0.0% | 0.00% | – |
| Q3 2022 | $3,000 | 0.0% | 344 | 0.0% | 0.00% | – |
| Q2 2022 | $3,000 | -75.0% | 344 | -72.7% | 0.00% | – |
| Q1 2022 | $12,000 | +50.0% | 1,262 | +2.9% | 0.00% | – |
| Q4 2021 | $8,000 | -20.0% | 1,227 | +8.3% | 0.00% | – |
| Q3 2021 | $10,000 | -16.7% | 1,133 | 0.0% | 0.00% | – |
| Q2 2021 | $12,000 | -29.4% | 1,133 | -24.1% | 0.00% | – |
| Q1 2021 | $17,000 | -46.9% | 1,492 | +64.9% | 0.00% | – |
| Q4 2020 | $32,000 | +146.2% | 905 | -3.8% | 0.00% | – |
| Q3 2020 | $13,000 | +85.7% | 941 | +111.5% | 0.00% | – |
| Q2 2020 | $7,000 | +16.7% | 445 | -32.4% | 0.00% | – |
| Q1 2020 | $6,000 | – | 658 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Acuitas Investments, LLC | 125,242 | $413,299 | 0.24% |
| Lion Point Capital, LP | 90,794 | $299,620 | 0.13% |
| Greenwich Wealth Management LLC | 76,341 | $252 | 0.03% |
| Wealth Advisors of Iowa, LLC | 11,699 | $38,606 | 0.03% |
| Marquette Asset Management, LLC | 25,760 | $85,008 | 0.02% |
| Key FInancial Inc | 10,927 | $36,059 | 0.01% |
| Paladin Advisory Group, LLC | 4,387 | $14,477 | 0.01% |
| Blackstone Inc. | 468,145 | $1,544,879 | 0.01% |
| Leucadia National | 120,651 | $398,148 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 47,643 | $157,222 | 0.00% |